GB201609464D0 - Novel 9-aminoanthracyclines with high cytotoxic activity for use as payloads in antibody-drug conjugates - Google Patents

Novel 9-aminoanthracyclines with high cytotoxic activity for use as payloads in antibody-drug conjugates

Info

Publication number
GB201609464D0
GB201609464D0 GBGB1609464.1A GB201609464A GB201609464D0 GB 201609464 D0 GB201609464 D0 GB 201609464D0 GB 201609464 A GB201609464 A GB 201609464A GB 201609464 D0 GB201609464 D0 GB 201609464D0
Authority
GB
United Kingdom
Prior art keywords
aminoanthracyclines
payloads
antibody
novel
cytotoxic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1609464.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toxinvent Ou
Original Assignee
Toxinvent Ou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toxinvent Ou filed Critical Toxinvent Ou
Priority to GBGB1609464.1A priority Critical patent/GB201609464D0/en
Publication of GB201609464D0 publication Critical patent/GB201609464D0/en
Priority to US16/303,861 priority patent/US10668166B2/en
Priority to PCT/EP2017/062989 priority patent/WO2017207540A1/en
Priority to EP17728476.7A priority patent/EP3464294B1/en
Ceased legal-status Critical Current

Links

GBGB1609464.1A 2016-05-30 2016-05-30 Novel 9-aminoanthracyclines with high cytotoxic activity for use as payloads in antibody-drug conjugates Ceased GB201609464D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB1609464.1A GB201609464D0 (en) 2016-05-30 2016-05-30 Novel 9-aminoanthracyclines with high cytotoxic activity for use as payloads in antibody-drug conjugates
US16/303,861 US10668166B2 (en) 2016-05-30 2017-05-30 Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment
PCT/EP2017/062989 WO2017207540A1 (en) 2016-05-30 2017-05-30 Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment
EP17728476.7A EP3464294B1 (en) 2016-05-30 2017-05-30 Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1609464.1A GB201609464D0 (en) 2016-05-30 2016-05-30 Novel 9-aminoanthracyclines with high cytotoxic activity for use as payloads in antibody-drug conjugates

Publications (1)

Publication Number Publication Date
GB201609464D0 true GB201609464D0 (en) 2016-07-13

Family

ID=56410733

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1609464.1A Ceased GB201609464D0 (en) 2016-05-30 2016-05-30 Novel 9-aminoanthracyclines with high cytotoxic activity for use as payloads in antibody-drug conjugates

Country Status (1)

Country Link
GB (1) GB201609464D0 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10668166B2 (en) 2016-05-30 2020-06-02 Toxinvent Ou Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10668166B2 (en) 2016-05-30 2020-06-02 Toxinvent Ou Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment

Similar Documents

Publication Publication Date Title
IL278891A (en) Anti-her2 antibody-drug conjugates, compositions comprising same and uses thereof
IL290116A (en) Hydrophilic antibody-drug conjugates
IL248221B (en) Antibody-drug conjugates with high drug loading
HK1231367A1 (en) Antibody-drug conjugates, their preparation and their therapeutic use
IL250711A0 (en) Conjugates comprising cell-binding agents and cytotoxic agents
HK1219422A1 (en) Conjugates comprising cell-binding agents and cytotoxic agents
IL247700A0 (en) Stable formulations for anti-cd19 antibodies and antibody-drug conjugates
GB201506402D0 (en) Site-specific antibody-drug conjugates
GB201506407D0 (en) Site-specific antibody-drug conjugates
PT3102244T (en) Antibody-drug conjugates and immunotoxins
GB201506399D0 (en) Site-specific antibody-drug conjugates
GB201506405D0 (en) Site-specific antibody-drug conjugates
PL3102606T3 (en) Antibody-drug conjugates and immunotoxins
GB201506389D0 (en) Site-specific antibody-drug conjugates
GB201506393D0 (en) Site-specific antibody-drug conjugates
IL254258A0 (en) Cryptophycin-based antibody-drug conjugates with novel self-immolative linkers
GB201506388D0 (en) Site-specific antibody-drug conjugates
HK1257352A1 (en) Gcc-targeted antibody-drug conjugates
GB201506394D0 (en) Site-specific antibody-drug conjugates
HK1219423A1 (en) Conjugates comprising cell-binding agents and cytotoxic agents
GB201615725D0 (en) Novel cytotoxic agents and conjugates thereof
GB201609464D0 (en) Novel 9-aminoanthracyclines with high cytotoxic activity for use as payloads in antibody-drug conjugates
GB201703503D0 (en) Novel 9-aminoanthracyclines with two oxazolidine cycles having high cytotoxic activity for use as payloads in antibodydrug conjugates (ADC-s)
GB201512199D0 (en) Site-specific antibody-drug conjugates
GB201512201D0 (en) Site-specific antibody-drug conjugates

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)